Optune Gadget Approved for Newly Diagnosed Brain Cancer: – TUESDAY, Oct. 6, 2015 – – The U.S http://priligyes.com/lo-que-debes-saber-sobre-la-eyaculaci%C3%B3n-precoz.html . Food and Medication Administration on Mon expanded its authorization for the Optune device to include newly diagnosed glioblastoma multiforme, an aggressive brain cancers. Optune involves placing electrodes on the surface of the scalp to deliver low-strength pulses called tumor treatment areas, which are designed to damage developing tumor cells, the company said in a information release.
Deborah Paul-Cheadle, RN, CIC is second writer. Related StoriesHealthcare technology social event of the entire year opens entriesBoston Children's and Rock Health synergy to accelerate development of pediatric health technologiesChildren's Memorial Hermann Hospital presents Halloween protection tipsThe paper deals with preventative measures that address the mounting Surgical Site Infections, or SSI, that account for 500 approximately, 000 hospital-acquired infections in the United States each full year, according to the federal government Centers for Disease Control and Avoidance . While skin asepsis technology cannot eliminate deaths from such infections, the analysis reported in the paper shows that a systems approach might help prevent these hospital-structured infections.